| Primary |
| Product Used For Unknown Indication |
50.0% |
| Depression |
4.8% |
| Hiv Infection |
4.8% |
| Insomnia |
4.2% |
| Suicide Attempt |
4.2% |
| Anxiety |
3.6% |
| Sleep Disorder Therapy |
3.6% |
| Drug Abuse |
3.0% |
| Intentional Drug Misuse |
3.0% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Drug Withdrawal Syndrome |
2.4% |
| Lung Disorder |
2.4% |
| Pain |
2.4% |
| Arthralgia |
1.8% |
| Back Pain |
1.8% |
| Alcohol Withdrawal Syndrome |
1.2% |
| Asthma |
1.2% |
| Contraception |
1.2% |
| Headache |
1.2% |
| Hypertension |
1.2% |
|
| Suicide Attempt |
15.1% |
| Vomiting |
9.4% |
| Liver Injury |
7.5% |
| Overdose |
7.5% |
| Intentional Self-injury |
5.7% |
| Multiple Drug Overdose |
5.7% |
| Substance Abuse |
5.7% |
| Agitation |
3.8% |
| Convulsion |
3.8% |
| Hepatic Enzyme Increased |
3.8% |
| Hepatic Necrosis |
3.8% |
| Intentional Overdose |
3.8% |
| Metabolic Acidosis |
3.8% |
| Product Quality Issue |
3.8% |
| Self Injurious Behaviour |
3.8% |
| Toxic Epidermal Necrolysis |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Accidental Overdose |
1.9% |
| Completed Suicide |
1.9% |
| Confusional State |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
30.7% |
| Insomnia |
11.2% |
| Sleep Disorder |
7.0% |
| Foetal Exposure During Pregnancy |
6.3% |
| Nasopharyngitis |
4.7% |
| Headache |
4.2% |
| Drug Abuse |
3.7% |
| Pain |
3.7% |
| Anxiety |
3.3% |
| Depression |
3.3% |
| Back Pain |
3.0% |
| Mental Status Changes |
2.8% |
| Suicide Attempt |
2.8% |
| Attention Deficit/hyperactivity Disorder |
2.3% |
| Multiple Sclerosis |
2.1% |
| Clostridial Infection |
1.9% |
| Hypertension |
1.9% |
| Muscle Spasticity |
1.9% |
| Smoking Cessation Therapy |
1.9% |
| Migraine |
1.6% |
|
| Pain |
10.7% |
| Vomiting |
8.9% |
| Drug Ineffective |
7.1% |
| Hepatic Failure |
7.1% |
| Suicidal Ideation |
7.1% |
| Acute Hepatic Failure |
5.4% |
| Overdose |
5.4% |
| Toxicity To Various Agents |
5.4% |
| Abnormal Behaviour |
3.6% |
| Chest Pain |
3.6% |
| Dizziness |
3.6% |
| Hepatic Enzyme Increased |
3.6% |
| Hyponatraemia |
3.6% |
| Insomnia |
3.6% |
| Intentional Overdose |
3.6% |
| Mental Status Changes |
3.6% |
| Musculoskeletal Pain |
3.6% |
| Sensory Disturbance |
3.6% |
| Somnolence |
3.6% |
| Suicide Attempt |
3.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.9% |
| Drug Use For Unknown Indication |
7.2% |
| Pain |
6.5% |
| Insomnia |
6.1% |
| Rheumatoid Arthritis |
4.7% |
| Hypertension |
4.5% |
| Depression |
3.7% |
| Sleep Disorder |
3.3% |
| Multiple Sclerosis |
3.1% |
| Diabetes Mellitus |
2.7% |
| Nausea |
2.6% |
| Blood Cholesterol Increased |
2.2% |
| Arthritis |
2.1% |
| Prophylaxis |
1.9% |
| Back Pain |
1.8% |
| Drug Therapy |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Headache |
1.8% |
| Osteoporosis |
1.7% |
| Anxiety |
1.6% |
|
| Vomiting |
13.6% |
| Weight Decreased |
9.7% |
| Weight Increased |
9.3% |
| Drug Ineffective |
7.0% |
| Headache |
5.8% |
| Pain |
5.4% |
| Rash |
4.7% |
| Urticaria |
4.7% |
| Pyrexia |
4.3% |
| Transient Global Amnesia |
4.3% |
| Flushing |
3.9% |
| Pruritus |
3.9% |
| Dizziness |
3.1% |
| Pulmonary Embolism |
3.1% |
| Tachycardia |
3.1% |
| White Blood Cell Count Increased |
3.1% |
| Diarrhoea |
2.7% |
| Nausea |
2.7% |
| Urinary Tract Infection |
2.7% |
| White Blood Cell Count Decreased |
2.7% |
|
| Interacting |
| Asthma |
31.6% |
| Back Pain |
10.5% |
| Headache |
10.5% |
| Hypothyroidism |
10.5% |
| Insomnia |
10.5% |
| Sleep Disorder |
10.5% |
| Smoking Cessation Therapy |
10.5% |
| Gastrointestinal Cancer Metastatic |
5.3% |
|
| Rash |
50.0% |
| Metabolic Acidosis |
25.0% |
| Renal Failure |
25.0% |
|
